# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Robert Peary (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX004-SYN-TD
- Date: 1919-01-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Thaddeus Lindgren-Okafor, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Eight-day review with the reticulocyte response, seen the same day by hematology. **S**

## History of present illness

Admiral Peary returns eight days after starting cyanocobalamin and is seen by Dr. Abernethy-Kwan of hematology on the same day. He has had five of the seven loading injections, given by the clinic nurse every other day. His tongue is less sore and he has a little more energy, though he is still breathless on the stairs. The numbness and pins and needles in his feet are unchanged; he has had no falls, and he checks his feet each morning. He has had no palpitations, muscle cramps or weakness. His potassium, planned with the second injection, was not drawn then. Blood for intrinsic factor and parietal cell antibodies, gastrin and thyroid antibodies was drawn this morning before his fifth injection. **S**

| Element | Detail |
|---|---|
| Injections | Five of seven loading doses given |
| Symptoms | Tongue better, slightly more energy; breathless on stairs; feet unchanged |
| Reticulocytes | 7.9%, from 0.4% |
| Hemoglobin | 8.9 g/dL, from 8.2 |
| Potassium | 3.6 mmol/L |
| Antibodies | Intrinsic factor antibody 38.5 AU/mL; parietal cell antibody 96.0; gastrin 820 pg/mL; thyroid peroxidase antibody 6 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired, a little better |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Positive | Breathless on one flight of stairs |
| Gastrointestinal | Positive | Tongue less sore; no indigestion, black stools or weight loss |
| Neurological | Positive | Numbness and tingling in both feet; no falls |

5 systems reviewed. **S**

## Current medications

- Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/68 mmHg; pulse 94 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 72.6 kg; BMI 21.7 kg/m². All vital signs are synthetic.

Hemoglobin: 8.9 g/dL (low); MCV: 114 fL (high); White blood cells: 4.6 10*3/uL; Platelets: 186 10*3/uL; Reticulocytes: 7.9% (high); Potassium: 3.6 mmol/L; Intrinsic factor antibody: 38.5 [arb'U]/mL (high); Parietal cell antibody: 96 [arb'U]/mL (high); Gastrin (fasting): 820 pg/mL (high); Thyroid peroxidase antibody: 6 [IU]/mL. All results are synthetic.

## Change since baseline

- Hemoglobin: 8.2 g/dL (low) at baseline, 8.9 g/dL (low) at this visit **S**
- MCV: 118 fL (high) at baseline, 114 fL (high) at this visit **S**
- White blood cells: 3.4 10*3/uL (low) at baseline, 4.6 10*3/uL at this visit **S**
- Platelets: 118 10*3/uL (low) at baseline, 186 10*3/uL at this visit **S**
- Reticulocytes: 0.4% (low) at baseline, 7.9% (high) at this visit **S**
- Potassium: 4.1 mmol/L at baseline, 3.6 mmol/L at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Pale; slight yellow tinge to the eyes; blood pressure 122/68, pulse 94 |
| Mouth | Tongue smooth but less red |
| Cardiovascular | Soft systolic flow murmur; no edema |
| Neurological | Vibration absent at the ankles and reduced at the knees; joint position sense impaired at both great toes; ankle jerks absent, knee jerks brisk, plantar responses flexor; Romberg positive; gait broad-based and slow |
| Feet | Healed stumps of the second to fifth toes on both feet; callus under the right first metatarsal head; skin intact; pulses present |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Pernicious anemia** (D51.0). Dr. Abernethy-Kwan confirms pernicious anemia: severe vitamin B12 deficiency with a high methylmalonic acid, a positive intrinsic factor antibody, which is highly specific, a positive parietal cell antibody and a high gastrin from loss of acid-producing cells. The reticulocyte peak of 7.9% at day 8 confirms the response. No transfusion is needed: he is stable at rest and his count is rising. **S**
   - Finish the seven loading doses, then cyanocobalamin 1,000 micrograms weekly, self-injected, until the nerves stop improving, then monthly for life.
   - Upper endoscopy with biopsies, with a screening colonoscopy at the same session.
   - Standing order for potassium with any future loading course.
2. **Subacute combined degeneration** (G32.0). Posterior column and peripheral nerve signs unchanged after one week, as expected; recovery takes months and may be incomplete. **S**
   - Physical therapy for balance and gait.
   - Neurological examination at each visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Symptoms: fatigue, breathlessness, exercise tolerance, sore tongue, numbness | Every visit during active treatment | Completed today | Tongue better and slightly more energy; breathless on stairs; feet unchanged |
| Laboratory | Reticulocyte count | About one week after the first injection | Completed today | 7.9% at day 8, from 0.4%: an appropriate response |
| Laboratory | Blood count with MCV | About eight weeks after starting replacement, with earlier checks in severe anemia | Completed today | Early check in severe anemia: hemoglobin 8.9 g/dL, MCV 114 fL, white cells 4.6, platelets 186 |
| Laboratory | Potassium | In the first days of treatment of severe anemia | Deferred | The potassium planned with the second injection on day 3 was not drawn. Today it is 3.6 mmol/L, at the low end of normal, with no cramps, weakness or palpitations, so no harm is evident. Corrective action: potassium checked at the next visit, and a standing order for potassium added to any future loading course |
| Laboratory | Cause of deficiency: intrinsic factor and parietal cell antibodies, gastrin | At diagnosis | Completed today | Intrinsic factor antibody 38.5 AU/mL and parietal cell antibody 96.0 positive; gastrin 820 pg/mL; drawn before today's injection |
| Laboratory | Autoimmune screening: TSH and thyroid antibodies; HbA1c | At diagnosis of autoimmune gastritis | Completed today | TSH 2.6 and HbA1c 5.5% at intake; thyroid peroxidase antibody 6 IU/mL today, negative |
| Medication safety | Transfusion threshold (restrictive, hemoglobin 7 to 8 g/dL, or symptoms at rest) | While hemoglobin is low | Completed today | Hemoglobin 8.9 g/dL and rising; no chest pain or breathlessness at rest; no transfusion |
| Medication safety | Injection plan: doses given, self-injection technique, site problems | Every visit | Completed today | Five of seven loading doses given; self-injection taught today for the weekly phase |
| Examination | Neurological examination: vibration, joint position, reflexes, Romberg, gait, cognition | At diagnosis and at follow-up visits for six weeks to three months, then until recovery levels off | Completed today | Unchanged from intake |
| Examination | Falls and gait: falls since the last visit, Timed Up and Go, home hazards | Every visit | Completed today | No falls; night lights fitted |
| Examination | Upper endoscopy with Sydney-protocol biopsies for autoimmune gastritis, neuroendocrine tumors and dysplasia | At diagnosis of pernicious anemia; then by individual risk | Ordered | Booked with a screening colonoscopy in four weeks |
| Self-management | Feet: daily skin checks, footwear, callus and stump skin, monofilament | Every visit | Completed today | Daily checks begun; skin intact; callus under the right first metatarsal head |
| Referral | Hematology consultation | At diagnosis | Completed today | Seen by Dr. Abernethy-Kwan today |
| Referral | Podiatry | Within four weeks of intake, then every three months | Ordered | Booked for the second week of February |
| Referral | Physical therapy for balance and gait | From diagnosis until balance recovers | Ordered | Starting next week |

## Goal progress

- Find the cause of the anemia and the numb feet. Outcome by 1919-01-21: Pernicious anemia confirmed: intrinsic factor and parietal cell antibodies positive, gastrin high. **S**
- Normal hemoglobin and MCV within eight weeks. In progress; target 1919-03-10. **S**
- Recover feeling and balance in the feet and walk without falls. In progress; target 1919-10-27. **S**
- No foot wound that goes unnoticed. In progress; target 1919-10-27. **S**
- Gastric surveillance planned with him. In progress; target 1919-03-10. **S**

## Guideline basis

- Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014), British Committee for Standards in Haematology (British Journal of Haematology 2014;166(4):496-513)
- Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024), National Institute for Health and Care Excellence
- AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021), American Gastroenterological Association (Gastroenterology 2021;161(4):1325-1332)
- CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026), Aether Forge
- Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) (2023), International Working Group on the Diabetic Foot (Diabetes/Metabolism Research and Reviews 2024;40(3):e3651)
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force

## Follow-up

- Last two loading doses with the nurse, then weekly self-injection. Five-week review on the day of the endoscopy and colonoscopy. Call for palpitations, cramps, weakness, a fall, or any wound on the feet. **S**
- Next scheduled visit 1919-02-17: five-week review on the day of upper endoscopy and colonoscopy: blood count, nerves, falls and feet. **S**
